Treatment Guidelines for Candida Albicans Infections

Introduction to Candida Treatment

The American College of Physicians recommends fluconazole as the preferred first-line therapy for most Candida albicans infections, with specific dosing and duration determined by infection site and severity, while critically ill patients should receive an echinocandin initially 1

For non-critically ill patients with documented susceptible C. albicans isolates, the Infectious Diseases Society of America recommends fluconazole 400 mg (6 mg/kg) daily as the appropriate first-line therapy 2, 1
In critically ill patients, the Infectious Diseases Society of America suggests initiating treatment with an echinocandin (caspofungin 50-70 mg daily, micafungin 100 mg daily, or anidulafungin 100 mg daily) rather than fluconazole, then de-escalate to fluconazole once the patient stabilizes and susceptibility is confirmed 2, 1
The Infectious Diseases Society of America recommends continuing treatment for at least 14 days after documented clearance of Candida from bloodstream and complete resolution of symptoms 2, 1
The American College of Physicians recommends removing all central venous catheters whenever feasible, as this significantly improves outcomes 1

For neonates with disseminated candidiasis, the Pediatric Infectious Diseases Society recommends fluconazole 12 mg/kg daily if C. albicans is isolated 3, 1
The Infectious Diseases Society of America recommends reducing fluconazole dose based on creatinine clearance in patients with renal impairment 1

For fluconazole-resistant Candida species, the Infectious Diseases Society of America suggests therapy with an echinocandin (caspofungin, micafungin, or anidulafungin) 3

The American College of Physicians recommends always obtaining cultures and susceptibility testing before finalizing therapy 1
The Infectious Diseases Society of America recommends confirming diagnosis with wet-mount preparation using 10% KOH to visualize yeast or pseudohyphae, and verifying normal vaginal pH (≤4.5) for vulvovaginal candidiasis 4

The American College of Physicians recommends fluconazole 400 mg daily for prophylaxis during neutropenia in high-risk patients 1